347. DEVELOPMENT OF THORACIC AORTIC ANEURYSMS IN PATIENTS WITH POLYMYALGIA RHEUMATICA: UNDERDIAGNOSED GIANT CELL ARTERITIS?

  • Scolnik M
  • Zucaro N
  • Mollerach F
  • et al.
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: Polymyalgia Rheumatica (PMR) and Giant Cell Arteritis (GCA) are close-related entities. Imaging studies have suggested that subclinical in-flammation of the large arteries is frequent in patients with apparently isolated PMR. Our objective was tocompare characteristics of PMR patients who devel-oped a thoracic aortic aneurysm (TAA) during follow-up with those who did not, in order to identify clinical features that may predict aortic involvement in clinical PMR patients. Methods: All electronic medical records of PMR patients diagnosed after the year 2000 (fulfilling ACR 2012 criteria) from a university hospital-based health management organization (HMO) were reviewed. Patients with a previous diagnosis of aortic aneurysm, those who developed clinical GCA or other rheumatic disease after PMR diagnosis and those lost in follow-up or without appropriate thoracic images after diagnosis, were excluded. A case-control study (PMR-TAA versus PMR without TAA) was performed and patients' characteristics were compared. A multivariate logistic regression analysis was performed to identify risk factors for TAA. Results: 350 PMR patients were included and 50 (14.3%, 95% CI 10.9-18.4) developed a TAA during a median follow up of 5.4 years (IQR 2.9-7.9). 18 TAAwere located at the aortic root and 32 at the ascending aorta, with a medium size at diagnosis of 4.3 cm (SD 0.33). No ruptures or dissections occurred but 5 patients (10 %, 95% CI 4.2-22.1) required surgery. Traditional cardiovascular risk factors and clinical characteristics of PMR were similar across groups, ex-cept for less statin use and longer treatment with steroids in the PMR-TAA group. In the multivariate analysis, being a male (OR 4,4, CI 2.3-8.6, p <0.001) and months of corticosterioid treatment, (OR 1.02, 95% CI 1.01-1.03, p 0.01) were associated with an increased risk of TAA. Statin use seemed to be protective, although did not reach statistical significance (OR: 0.48, 95% CI 0.23-1.002; p=0.051). Conclusions: 14.3 % of patients with apparently isolated PMR developed a thoracic aortic aneurysm. Screening with thoracic images in PMR male pa-tients and those PMR patients requiring a prolonged corticosteroid use may be advisable.

Cite

CITATION STYLE

APA

Scolnik, M., Zucaro, N. M., Mollerach, F., Scaglioni, V., Giudice, L. L., Perez, J. M., … Soriano, E. (2019). 347. DEVELOPMENT OF THORACIC AORTIC ANEURYSMS IN PATIENTS WITH POLYMYALGIA RHEUMATICA: UNDERDIAGNOSED GIANT CELL ARTERITIS? Rheumatology, 58(Supplement_2). https://doi.org/10.1093/rheumatology/kez063.071

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free